RecruitingNot ApplicableNCT07141589

Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment Surgeries

Fentanyl Versus Ketorolac as an Adjuvant to Peribulbar Block for Anterior Segment Surgeries, A Prospective Double-blinded Randomized Controlled Study


Sponsor

Cairo University

Enrollment

168 participants

Start Date

Aug 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study aims to compare the efficacy of ketorolac and fentanyl as adjuvants to local anesthetics for anterior segment surgeries of the eye.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age over 18 years old.
  • Both sexes.
  • American Society of Anesthesiologists (ASA) physical status I-III.
  • Scheduled to undergo operations for anterior segment surgeries of the eye under local (peribulbar) anesthesia.

Exclusion Criteria7

  • Patient's refusal.
  • Known allergy or hypersensitivity to aspirin or nonsteroidal anti-inflammatory medications.
  • Patients with contraindications to local anesthetics, such as high axial length or patients with high preoperative intraocular pressure.
  • If cases develop severe pain intraoperatively from the start, necessitating rescue analgesia and sedation or requiring conversion to general anesthesia.
  • Infection at the site of injection.
  • Patients with coagulopathies or on anticoagulants.
  • Impaired renal function.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGLidocaine + Bupivacaine + Hyaluronidase

Patients will receive a mixture of 3 ml lidocaine 2%, 3 ml bupivacaine 0.5%, and hyaluronidase 60 IU diluted in normal saline to a total volume of 8 ml.

DRUGFentanyl + Lidocaine + Bupivacaine + Hyaluronidase

Patients will receive a mixture of 3 ml lidocaine 2%, 3 ml bupivacaine 0.5%, and hyaluronidase 60 IU and fentanyl 20 μg diluted in normal saline to a total volume of 8 ml.

DRUGKetorolac + Lidocaine + Bupivacaine + Hyaluronidase

Patients will receive a mixture of 3 ml lidocaine 2%, 3 ml bupivacaine 0.5%, hyaluronidase 60 IU, and ketorolac 15 mg diluted in normal saline to a total volume of 8 ml.


Locations(1)

Cairo University

Cairo, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07141589


Related Trials